IL-1β Signalling Modulates T Follicular Helper and Regulatory Cells in Human Lymphoid Tissues
Listed in
This article is not in any list yet, why not save it to one of your lists.Abstract
Background
Dysregulation of the T follicular helper (Tfh) and T follicular regulatory (Tfr) homeostasis in the germinal center (GC) can result in antibody-mediated autoimmunity. While interleukin-1β (IL-1β) has been shown to be an important modulator of the GC response in animal models via the expression of IL-1 agonist (IL-1R1) and antagonist (IL-1R2) receptors on follicular T cells, such regulation has not yet been studied in humans.
Methods
We investigated Tfh and Tfr phenotypes in human secondary lymphoid organs — namely tonsils, spleens, and mesenteric lymph nodes — using flow cytometry, single-cell transcriptomics, and in vitro cell culture. We also benchmarked our findings with a cohort of patients with autoimmune and inflammatory diseases.
Results
We found that Tfh and Tfr cells exhibit organ-specific phenotypes related to their activation status and IL-1 receptor expression. An excess of IL-1R1 over IL-1R2 was linked to the emergence of a unique activated Tfr subset that combines features of both Treg and GC-Tfh cells. Single-cell transcriptomics and in vitro studies showed that IL-1β signaling through IL-1R1 promotes follicular T-cell activation. Inhibiting IL-1β resulted in upregulation of IL-1R1 expression, showing a fine-tuned regulation. In autoimmune patients, high IL-1β and circulating Tfr levels correlated with higher autoantibody levels, linking inflammation, IL-1β signaling, and the Tfr/Tfh balance.
Conclusions
Our study underscores the pivotal role of IL-1β in follicular T-cell activation, contributing to pathological antibody production in humans. Targeting IL-1β signaling in Tfh and Tfr cells could offer new treatment strategies for antibody-mediated autoimmune diseases.
